Markets › India › NSE › MANGALAM

Mangalam Drugs & Organics Ltd

NSE:MANGALAMHealthcare

₹28.65−3.11%At closeAt close · Fri 23 Oct · ≈ AED 1.11 · Market cap $4.87M

Ratio	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026	Current · undated	YoY
Gross margin	25.7%	12.2%	7.8%	5.1%	47.3%	10.0%	—	—
Operating margin	11.7%	8.0%	4.1%	0.3%	5.5%	−14.3%	−14.3%	+0.0 pts
Net margin	7.4%	4.4%	0.3%	−2.5%	2.1%	−19.1%	−19.1%	+0.0 pts
EBITDA margin	14.5%	10.1%	7.0%	4.8%	11.4%	−6.4%	—	—
Return on equity	21.4%	13.1%	0.8%	−6.7%	4.5%	−43.1%	−43.1%	+0.0 pts
Return on assets	10.6%	6.0%	0.4%	−2.7%	1.8%	−14.1%	−14.1%	+0.0 pts
Return on capital employed	28.7%	17.9%	7.8%	0.6%	10.0%	−28.0%	—	—
Debt / equity	0.5×	0.6×	0.6×	0.8×	0.6×	1.0×	1.0×	+0.0%
Debt / assets	26.4%	26.8%	24.6%	32.1%	26.3%	33.5%	—	—
Interest coverage	4.8×	3.2×	1.7×	0.1×	1.2×	−2.0×	—	—
Current ratio	1.2×	1.4×	1.2×	1.1×	1.0×	0.8×	0.8×	+0.0%
Quick ratio	0.7×	0.5×	0.4×	0.3×	0.3×	0.3×	—	—
Cash ratio	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	+0.0%
Asset turnover	1.4×	1.4×	1.0×	1.1×	0.9×	0.7×	—	—
Inventory turnover	4.8×	3.4×	2.5×	2.8×	1.2×	2.0×	—	—
Receivables turnover	6.7×	9.6×	8.0×	13.1×	7.9×	5.8×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—

Margins, returns, leverage and liquidityUpdated Tue 31 Mar ·

ⓘ

Current snapshot ratios have no reporting date and are shown separately from fiscal periods.